Wantstats
Company ProfilePremium

Elanco

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Elanco - Healthcare showcase

Year Founded & Workforce

1954

5,800 Employees

Industry

Healthcare

Services

Cattle vaccinesPoultry VaccinesCatsSwineNonsteroidal Anti-Inflammatory Drugs (NSAIDs)
E

Elanco Employee Contacts

25 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Elanco Overview

Company Headquarters: Greenfield, Indiana, United States

Founded: 1954

Workforce: 5,800+

Company Working: Elanco develops and markets products related to animal health all over the world. The company operates through five segments, namely, beef, dairy, poultry, swine, and dogs. The company has a strong presence in more than 90 countries and offers more than 125 brands to the customers. The company was a part of the Eli Lilly group, but due to the spinoff of animal health division Elanco became a separate entity and filed IPO registration.

Company Snapshot

$3,271M

Revenue

5,800

Employees

1954

Founded

Greenfield, Indiana, United States

Headquarters

SWOT Analysis

Strengths

  • Diversified solution portfolio of products and services
  • Unique set of offerings for customers
  • Strong global foothold
  • Well-developed distribution channel

Weaknesses

  • Dependence on limited business segments
  • Legal complications in patents filling

Opportunities

  • Worldwide expansion through strategic partnerships or mergers and acquisitions

Threats

  • Government rules and regulations
  • Strong competition from rivals

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Elanco
    • Cattle vaccines
    • Poultry Vaccines
    • Cats
    • Swine
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 3,271 Mn in 2020 to USD 4,411 Mn in 2022.
Elanco — By Business Segment
Series (USD Mn)202020212022
Sales3,2714,7644,411
R&D329369321

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →